Evidence map›Paper›PMID 35219326›Full record

ArticleReproductive biology and endocrinology : RB&E2022

FTO protects human granulosa cells from chemotherapy-induced cytotoxicity.

Rongli Wang, Wei Wang, Lijun Wang, Linnan Yuan, Feiyan Cheng, Xin Guan, Nini Zheng, Xinyuan Yang

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MJournal of nanobiotechnology · 2024
    Article
  10. Article
  11. TiJournal of nanobiotechnology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rongli WangDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Wei WangDepartment of Anesthesiology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Lijun WangDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Linnan YuanDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Feiyan ChengDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Xin GuanDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Nini ZhengDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
Xinyuan YangDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China. 2215275634@qq.com.ORCID http://orcid.org/0000-0001-8831-3076
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

National Natural Science Foundation of China 81571393Natural Science Foundation of Shaanxi Province 2019KW-065Project A of the First Affiliated Hospital of Xi'an Jiaotong University XJTU-2021-02
6 · The paper itself

Abstract

backgroundPremature ovarian failure (POF) is a serious problem for young women who receive chemotherapy, and its pathophysiological basis is the dysfunction of granulosa cells. According to previous reports, menstrual-derived stem cells (MenSCs) can restore ovarian function and folliculogenesis in mice with chemotherapy-induced POF. Fat mass- and obesity-associated (FTO) was reported to be associated with oocyte development and maturation. FTO was decreased in POF and may be a biomarker for the occurrence of POF. Knockdown of FTO in granulosa cells promoted cell apoptosis and inhibited proliferation. But the relationship between FTO and ovarian repair was still unclear. This study was aimed at investigating the FTO expression level and the role of FTO in the MenSCs recovering the function of injured granulosa cells.

methodFirst, cisplatin was used to establish a granulosa cell injury model. Then, the MenSCs and injured granulosa cell coculture model and POF mouse model were established in this study to explore the role of FTO. Furthermore, gain- and loss-of-function studies, small interfering RNA transfection, and meclofenamic acid (MA), a highly selective inhibitor of FTO, studies were also conducted to clarify the regulatory mechanism of FTO in granulosa cells.

resultsMenSCs coculture could improve the function of injured granulosa cells by increasing the expression of FTO. MenSCs transplantation restored the expression of FTO in the ovaries of POF mice. Overexpression of FTO restored the injured cell proliferation and decreased apoptosis by regulating the expression of BNIP3. Down-regulation of FTO got the opposite results.

conclusionsIn the treatment of MenSCs, FTO has a protective effect, which could improve the viability of granulosa cells after cisplatin treatment by decreasing the expression of BNIP3. Meanwhile, FTO may provide new insight into therapeutic targets for the chemotherapy-induced POF.

Indexed as

AdultAlpha-Ketoglutarate-Dependent Dioxygenase FTOAnimalsAntineoplastic AgentsApoptosisCells, CulturedCisplatinCytoprotectionDisease Models, AnimalFemaleGranulosa CellsHumansMiceMice, Inbred C57BLPrimary Ovarian InsufficiencyAlpha-Ketoglutarate-Dependent Dioxygenase FTOAntineoplastic AgentsCisplatinFTO protein, humanFTO protein, mouseBNIP3FTOMenstrual-derived stem cellsPOF

Identifiers

PMID35219326
PMCPMC8881882
OpenAlexW4214762418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.